Barclays

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
9,146
Total Value
175908309
Accession Number
0000312069-25-000408
Form Type
13F-HR
Manager Name
Barclays
Data Enrichment
89% identified
8,179 identified967 unidentified

Holdings

9,146 positions • $175.9M total value
Manager:
Search and click to pin securities to the top
Page 211 of 226
122017AB2
Shares:
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
55445L100
Shares:353
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
46137Y872
Shares:200
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
83425V104
Shares:29.1K
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
ESS Tech, Inc.
Shares:1.7K
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
TRAVELZOO
Shares:321
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
Seaport Entertainment Group Inc.
Shares:220
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
00888H406
Shares:155
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
TAT TECHNOLOGIES LTD
Shares:175
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
Cue Biopharma, Inc.
Shares:6.0K
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
30162V607
Shares:24.9K
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
ProPhase Labs, Inc.
Shares:12.6K
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
86333MAA6
Shares:
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
MERCER INTERNATIONAL INC.
Shares:754
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
00888H687
Shares:174
Value:$5.0K
% of Portfolio:0.0% ($5.0K/$175.9M)
Alzamend Neuro, Inc.
Shares:4.4K
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$175.9M)
09075P204
Shares:1.9K
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$175.9M)
007408206
Shares:843
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$175.9M)
83304AAH9
Shares:
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$175.9M)
45782C821
Shares:115
Value:$4.0K
% of Portfolio:0.0% ($4.0K/$175.9M)